Sad-A Kinase Controls Islet Beta-Cell Size And Function As A Mediator Of Mtorc1 Signaling
Jia Nie,Xiaolei Liu,Brendan N Lilley,Hai Zhang,Y Albert Pan,Scot R Kimball,Jun Zhang,Weiping Zhang,Li Wang,Leonard S Jefferson,Joshua R Sanes,Xiao Han,Yuguang Shi
DOI: https://doi.org/10.1073/pnas.1307698110
2013-01-01
Abstract:The mammalian target of rapamycin (mTOR) plays an important role in controlling islet beta-cell function. However, the underlying molecular mechanisms remain poorly elucidated. Synapses of amphids defective kinase-A (SAD-A) is a 5' adenosine monophosphate-activated protein kinase-related protein kinase that is exclusively expressed in pancreas and brain. In this study, we investigated a role of the kinase in regulating pancreatic beta-cell morphology and function as a mediator of mTOR complex 1 (mTORC1) signaling. We show that global SAD-A deletion leads to defective glucose-stimulated insulin secretion and petite islets, which are reminiscent of the defects in mice with global deletion of ribosomal protein S6 kinase 1, a downstream target of mTORC1. Consistent with these findings, selective deletion of SAD-A in pancreas decreased islet beta-cell size, whereas SAD-A overexpression significantly increased the size of mouse insulinomas cell lines beta-cells. In direct support of SAD-A as a unique mediator of mTORC1 signaling in islet beta-cells, we demonstrate that glucose dramatically stimulated SAD-A protein translation in isolated mouse islets, which was potently inhibited by rapamycin, an inhibitor of mTORC1. Moreover, the 5'-untranslated region of SAD-A mRNA is highly structured and requires mTORC1 signaling for its translation initiation. Together, these findings identified SAD-A as a unique pancreas-specific effector protein of mTORC1 signaling.